Skip to main content

Table 5 Association between imaging findings and adverse clinical outcomes of COVID-19

From: Can initial chest CT scan predict status and clinical outcomes of COVID-19 infection? A retrospective cohort study

Outcomes

Imaging findings

Adjusteda OR (95% CI)

P value

ICU admission

Ground glass

0.42 (0.09–1.99)

0.274

Consolidation

2.23 (0.62–7.95)

0.218

Bilateral lung involvement

3.66 (0.38–35.23)

0.262

Peribronchovascular distribution

2.93 (1.92–4.47)

< 0.001

Involved zones

2.10 (1.55–2.86)

< 0.001

CSS (continuous)

1.14 (1.10–1.19)

< 0.001

CSS ≥ 19

3.21 (2.15–4.81)

< 0.001

Mortality

Consolidation

1.72 (0.63–4.65)

0.288

Peribronchovascular distribution

2.30 (1.50–3.53)

< 0.001

Involved zones

1.35 (1.05–1.74)

0.020

CSS (continuous)

1.08 (1.04–1.12)

< 0.001

CSS ≥ 19

1.84 (1.21–2.81)

0.004

Disease severityb

 Severe

Ground glass

0.51 (0.13–2.02)

0.337

Consolidation

4.94 (1.22–20.02)

0.025

Peribronchovascular distribution

2.06 (1.26–3.35)

0.004

Involved zones

1.68 (1.29–2.18)

0.001

CSS (continuous)

1.10 (1.06–1.14)

< 0.001

CSS ≥ 19

3.18 (2.05–4.93)

< 0.001

 Critical

Ground glass

0.28 (0.04–1.89)

0.195

Consolidation

3.06 (0.74–12.68)

0.123

Peribronchovascular distribution

4.62 (2.64–8.10)

< 0.001

Involved zones

3.21 (2.25–4.58)

< 0.001

CSS (continuous)

1.23 (1.16–1.29)

< 0.001

CSS ≥ 19

6.25 (3.74–10.41)

< 0.001

  1. OR odds ratio, CI confidence interval
  2. aAdjusted for patients’ comorbidities (cardiovascular diseases, asthma/chronic obstructive pulmonary disease, and diabetes) and imaging findings
  3. bBased on the World Health Organization criteria. “Moderate” disease was reference